KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacira BioSciences (PCRX) Other financing activities: 2009-2022

Historic Other financing activities for Pacira BioSciences (PCRX) over the last 9 years, with Dec 2022 value amounting to $1.2 million.

  • Pacira BioSciences' Other financing activities was N/A to $11.0 million in Q1 2017 from the same period last year, while for Mar 2017 it was $19.6 million, marking a year-over-year change of. This contributed to the annual value of $1.2 million for FY2022, which is 74.15% down from last year.
  • As of FY2022, Pacira BioSciences' Other financing activities stood at $1.2 million, which was down 74.15% from $4.5 million recorded in FY2021.
  • Pacira BioSciences' Other financing activities' 5-year high stood at $12.5 million during FY2020, with a 5-year trough of $1.2 million in FY2022.
  • In the last 3 years, Pacira BioSciences' Other financing activities had a median value of $4.5 million in 2021 and averaged $6.1 million.
  • Data for Pacira BioSciences' Other financing activities shows a maximum YoY crashed of 74.15% (in 2022) over the last 5 years.
  • Over the past 3 years, Pacira BioSciences' Other financing activities (Yearly) stood at $12.5 million in 2020, then tumbled by 63.59% to $4.5 million in 2021, then tumbled by 74.15% to $1.2 million in 2022.